2023 Psychiatric Pharmacotherapy Update • Now Fully On-Demand!
2023 Psychiatric Pharmacotherapy Update
The University of Texas at Austin College of Pharmacy
Thursday, Oct. 26 - Friday, Oct. 27, 2023 • NOW FULLY ON DEMAND!
About
The 2023 Psychiatric Pharmacotherapy Update offers 21 hours of CPE content. Registration includes Texas State Board of Pharmacy CE requirements, clinical updates, law updates and more. This program is now available fully on demand for homestudy credit.
Target Audience
This seminar is intended for pharmacists, psychiatrists, physicians, nurses, physician assistants, psychologists and social workers* who specialize in or have an interest in neuropsychiatric disorders and wish to enhance their awareness and knowledge of the most recent advances impacting contemporary practice.
*Social workers, please see the agenda to identify which sessions (*) have been designated as information that will meet your specific educational needs, and offer social work-specific continuing education credit. Please feel free to register for the entire conference if you wish to participate in the non-accredited sessions for your own professional development.
Attendance Options
Registrants have the option of joining us live in person in Austin, Texas or via live virtual broadcast. In addition to the live sessions, there will be additional on-demand content included with registration. All live presentations will be recorded and available for on-demand viewing throughout the next year. With many ways to participate, you can’t miss out.
For those joining us in person, visit our location pageon the Psychiatric Pharmacotherapy Update website for more information.
Registering and Accessing the Content
Psychiatric Pharmacotherapy Update registrants will access all seminar content on this page. Be sure to bookmark this page for accessing session content, live broadcast Zoom feeds and on-demand sessions. You are required to log into your account to access seminar content, so we recommend you keep your login email and password handy.
Register for 2023 Psychiatric Pharmacotherapy Update
NOTE: If you have previously registered for the live event, skip down to Log Back In.
First, you must register for the activity using the GREEN button at the bottom of the page.
(Note: If you have never claimed CE credit through this UT Austin College of Pharmacy CE site before, you will also be prompted to create a CE profile before you can register for this program).
Once you are registered & logged in, save your email & password for easier access when you return to complete additional sessions.
Click one of the sessions listed below and follow the instructions listed in that module.
If you wish to return to the program later, do so by following the instructions in the orange box below.
Log Back In
Bookmark this page. When you return, click on the "log in" link at the top right. (NOTE: this registration page is the same page you will use during the live event and for on-demand sessions later.)
Enter your email/password at the prompt.
Click one of the sessions listed below and follow the instructions in that module.
Fee
$525.00
CE Hours
21.00
CE Units
2.100
Support/Credits
Additional Event Information
Session content: Look to the tabs below for content. PDF copies of the presentation slides will be added in each session tab closer to the event day.
Zoom links for live broadcast: As we approach the event, Zoom links will be available below. There is one webinar link for each day. The program will broadcast a constant stream that you can leave and return to as you can. You will need to log into Zoom, but you can use a free Zoom account for this broadcast.
-- Zoom links to come. --
All content will be recorded: All content will be recorded for viewing online after the event – so if you miss a session, no worries. You will be able to see sessions over the next year (please allow 4 to 6 weeks for recordings to appear).
On-demand sessions: You can open the links below to find the on-demand videos embedded in the system. Recordings of the live sessions will be placed in the tabs in the same way.
Evaluations: You will be able to access and complete evaluations at the scheduled time the live session ends. If the speaker is to finish early, just know the evaluation will eventually become live at the originally scheduled time.
CE credit / certificate: Upon completing the online evaluations following each session. For pharmacy, the credit for that session will be automatically uploaded to the NAPB profile you entered in this system. For all other professions, you can download the certificate after completing evaluations via the "View/Print CE Cert" tab at the top of the page.
Thank you: We know you have options on where you get your CE. We greatly appreciate you choosing The University of Texas at Austin College of Pharmacy! Thank you!
Continuing Education Credit
Pharmacy
Continuing Pharmacy Education: The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This two-day activity is approved for 22.0 CEUs (14 contact hours live with 8 on-demand) of continuing education credit. In order to receive 22.00 contact hours of CE credit, the participant must attend/participate in all sessions of the program, and complete the online evaluations for each session.
Medical
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine and The University of Texas at Austin College of Pharmacy. The Joe R. & Teresa Lozano Long San Antonio School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Long School of Medicine designates this live activity for a maximum of 21.00 AMA PRA Category 1 Credits™ in-person or 21.00 online/on-demand. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Social Work / Counseling / APA
The Office of Professional Development at The University of Texas at Austin Steve Hicks School of Social Work is accredited by the Council on Social Work Education, and as such receives automatic approval as a continuing education provider by the Texas Board of Social Work Examiners under Texas Administrative Code, Title 22, Part 34. § 781.511(c). The program represented by this certificate was provided in accordance with the criteria and standards of the Texas State Board of Social Worker Examiners, and has been approved for Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists. Please note that 1 hour = 1 CEU. Complaints about this program may be made to TSBSWE 333 Guadalupe St, Tower 3, Room 900, Austin, TX 78701 • 512-305-7700 • 800-821-3205. Peer Counselor / Addition Counselor Provider Number: 2050-20
This activity has been accredited by University of Texas at Austin School of Nursing for up to 13 contact hours of live content and up to 7 hours of enduring content. University of Texas at Austin School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. The course “Human Trafficking Prevention” has been approved by the HHSC but does not include CNE credit. This activity’s enduring materials expire October 26, 2025.
Disclosures: Speakers who have disclosed relevant financial relationships:
Steven Saklad, PharmD – Alkermes as consultant
Roger Sommi, PharmD – Alkermes as speaker, receives research support, and serves on advisory board
Jeffrey Newport, MD - Janssen research grant recipient and serves on advisory board (ended)
Martina Guerrero, MD – Otsuka as speaker
Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.
Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.
Questions?
At any time, please email us atUTpharmacyCE@austin.utexas.edu– we monitor this email daily and will be monitoring it all day during the live event.
Psychopharmacology Myth-Busting: A Focus on Antidepressants
Learning Objectives
Compare commonly believed medication adverse effect myths to the facts from the literature.
Evaluate the evidence of common efficacy myths heard in practice to the facts from the literature.
Determine if common clinical myths in psychopharmacology are evidence-based.
About the Speaker
Tawny Smith, Pharm.D., BCPP
Associate Professor of Psychiatry
The University of Texas at Austin Dell Medical School
After graduating with her Pharm.D. degree, Dr. Smith completed a psychiatric pharmacy residency and clinical sciences fellowship in mental health outcomes at The University of Texas at Austin College of Pharmacy. She is a board-certified psychiatric pharmacist currently serving as an Associate Professor of Psychiatry and Behavioral Sciences for The University of Texas at Austin (UT), Dell Medical School. She also maintains an adjunct faculty appointment with the UT College of Pharmacy. She has outpatient practices at UT Health Austin Women's Reproductive Mental Health and Bipolar clinics and serves as a consultant for the Perinatal Psychiatry Access Network (PeriPAN). She is also the director of the psychopharmacology consult service at Ascension Seton Shoal Creek. She serves as one of the core faculty for the DMS psychiatry residency program where she has been awarded several teaching awards. She has delivered numerous educational presentations to the community and other health professionals at national and international conferences throughout her career. She has over 85 published abstracts, peer-reviewed articles and book chapters in the area of psychiatric pharmacy. She is an active member of the American Association for Psychiatric Pharmacists (AAPP) and is currently the chair for the Continuing Professional Development committee. She remains active in her community and serves on the Board of Directors for both the Austin Clubhouse, as well as the Hill Country chapter of the National Charity League.
Disclosure: Dr. Tawny Smith does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Marisa S.P. Toups, M.D.
Psychiatrist/Owner, Singularity Psychiatry and Mental Health
Affiliate Assistant Professor
UT Southwestern Medical School Department of Psychiatry
Dr. Toups is a board-certified psychiatrist and specialist in treatment-resistant depression. After medical school, she completed psychiatric training, including a specialty fellowship focusing on the study of treatment outcomes for Major Depressive Disorder, at UT Southwestern Medical Center in Dallas TX. As a faculty member at UT Southwestern and UT Austin Dell Medical School, she studied the role of immunity in major depression, as well as served as an investigator in numerous clinical trials. She is active in teaching evidence-based medicine, is the co-author of an award-winning journal club curriculum Journal Club Super Star, and co-hosts a related podcast, the Yeah, No Journal Club. She now runs her own practice, Singularity Psychiatry and Mental Health, where she provides expert psychiatric care for patients with complex depression.
Disclosure: Dr. Marisa Toups does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Orexins and Emerging Indications for Use in Psychiatry Beyond Insomnia
Learning Objectives
Discuss the physiologic function and distribution of excitatory neuropeptides orexin/hypocretin.
Review the orexin mechanism of currently FDA-approved agents targeting orexin/hypocretin.
Outline current research and possible future targets for these neuropeptides and their receptors, including addiction, inflammation, Alzheimer's disease, obesity and depression.
About the Speaker
Roger W. Sommi, Pharm.D., BCPP, FCCP
Professor Emeritus of Pharmacy Practice and Psychiatry
Division of Pharmacy Practice and Administration
UMKC School of Pharmacy
Dr. Sommi is Professor Emeritus at the UMKC School of Pharmacy - Department of Pharmacy Practice, with a cross-appointment in the Department of Psychiatry in the UMKC School of Medicine and is a Pharmacy Consultant for the Missouri Department of Mental Health. He received his BS in Pharmacy from the University of Wisconsin at Madison, Doctor of Pharmacy from the University of Utah, Residency in Hospital Pharmacy at the University of Utah Hospital and Fellowship in Psychopharmacy at the University of Texas at Austin. He is board-certified in Psychiatric Pharmacy Practice by the Board of Pharmaceutical Specialties and is a Fellow of the American College of Clinical Pharmacy.
Throughout his career, Dr. Sommi has been a preceptor, served as Associate Dean, been a research director, served as a founding member, Past President, and on various committees of the College of Psychiatric and Neurologic Pharmacists. He was actively involved in the establishment of Psychiatric Pharmacy as a specialty and worked to develop the recertification process for psychiatric pharmacy. Currently, he is involved with the regional Crisis Intervention Team training program in the Kansas City area and is a member of ACCP, AACP, APhA, Missouri Pharmacists Association, and the Missouri, Greater Kansas City and Mid-Missouri Society of Health-System Pharmacists.
Dr. Sommi’s area of research interest is primarily in outcomes associated with drug treatment of schizophrenia and other psychiatric disorders.
Disclosure: Dr. Roger Sommi has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:
Affiliation: Speaker, advisory board, research support
Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.
Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.
Summarize recent legal and regulatory changes impacting OUD care
Compare approved formulations of medications for OUD
Describe challenges in pharmacy access to buprenorphine
About the Speaker
Lindsey J. Loera, Pharm.D.
Assistant Professor of Practice
Assistant Director, Pharmacy Addictions Research & Medicine (PhARM) Program
The University of Texas at Austin College of Pharmacy
Dr. Lindsey J. Loera graduated from the University of Texas at Austin College of Pharmacy (UTCOP) and completed a two-year postgraduate research and teaching fellowship with the Pharmacy Addictions Research & Medicine (PhARM) Program. She is now an assistant professor of practice at the UTCOP and is the assistant director of the PhARM Program. In these roles, Dr. Loera conducts research that supports the Texas Targeted Opioid Response initiative and provides instruction in pharmacotherapy and interprofessional collaboration courses. In addition to these appointments, she serves as a faculty co-advisor to the UTCOP collegiate chapter of the American Association of Psychiatric Pharmacists (UT-AAPP). Dr. Loera has been recognized with prestigious research awards from ACCP and AACP. She is a recipient of the 2020 UTCOP Pharmacy Mortar & Pestle Award, a 2019 United States Public Health Service Excellence in Public Health Pharmacy Award, and the college's 2018 Benjamin Reed Leader in Pharmacy Award.
Disclosure: Dr. Lindsey Loera does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Novel Approaches to Metabolic Complications of Antipsychotic Treatment
Learning Objectives
Differentiate between traditional and new approaches to addressing antipsychotic-induced weight gain and metabolic complications.
Contrast the disparities facing individuals with serious mental illness versus the general population in treating antipsychotic-induced weight gain and metabolic complications.
About the Speaker
Troy A. Moore, Pharm.D., M.S., Pharm, BCPP
Director, ASHP Accredited PGY-1 Pharmacy Residency Program
Clinical Pharmacy Specialist, Mental Health
Rocky Mountain Regional VA Medical Center
Troy A. Moore received his Pharm.D. from the University of New Mexico College of Pharmacy in 2003. He subsequently attended the University of Texas at Austin College of Pharmacy, receiving his Master of Science in Pharmacy in 2005 while completing a 2-year Psychiatric Pharmacy Residency at the San Antonio State Hospital and the South Texas Veterans Health Care System (STVHCS). He joined the University of Texas Health Science Center at San Antonio Department of Psychiatry, Division of Schizophrenia and Related Disorders in 2005 and became Assistant Professor in 2007. He joined the STVHCS as Clinical Pharmacy Specialist in Psychiatry in 2010 where he served the Substance Abuse and Domiciliary Programs. He joined the VA Eastern Colorado Health Care System (ECHCS) in December 2018. He is the author of numerous publications, including the Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update and Ambulatory Detoxification in alcohol use disorder and opioid use disorder and is a reviewer for multiple psychiatric, substance abuse, and pharmacy journals.
He is currently the Director of the ASHP-accredited PGY-1 Pharmacy Residency at VA ECHCS, serves as the Co-Chair of the VHA PBM CPPO Substance Use Disorder Subject Matter Expert Workgroup, member of the CPNP Substance Use Disorders committee, and member of the VA ECHCS Research and Development Committee. Dr. Moore previously served as the Director of the ASHP-accredited PGY-2 Psychiatric Pharmacy Residency at STVHCS, Co-Director of the Advanced Fellowship in Addiction Treatment at STVHCS, Chair of the Board of Pharmacy Specialties Specialty Council on Psychiatric Pharmacy, the Member-at-Large on the Board of Director for the College of Psychiatric and Neurologic Pharmacists, and served as a handling editor for the Mental Health Clinician.
Disclosure: Dr. Troy Moore does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
Review pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs that have been released in the past five years.
About the Speaker
Stephen R. Saklad, Pharm.D., BCPP
Director, Psychiatric Pharmacy Program
Clinical Professor
The University of Texas at Austin College of Pharmacy
Dr. Saklad is a Clinical Professor at The University of Texas College of Pharmacy and a Pharmacist at San Antonio State Hospital since 1979. He has focused his career on clinical care, teaching, and research to improve the quality of life and function in the serious and persistently mentally ill. He helped to create a clinical research unit at San Antonio State Hospital and developed the first websites for The University of Texas College of Pharmacy and the College of Psychiatric and Neurologic Pharmacists (CPNP). He is the Director of the University of Texas Psychiatric Pharmacy Program in San Antonio, having trained over 70 advanced practice pharmacists in psychiatric pharmacy. Dr. Saklad is a Founding Member of CPNP, served on the CPNP Board of Directors and was the founding senior editor of their peer-reviewed journal, the Mental Health Clinician. He has published articles and presented to many groups around the country on a variety of pharmacy and mental health-related topics. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illnesses, as well as their pharmacokinetics and interactions. He has received several honors, most recently the Judith J. Saklad Memorial Award from CPNP in 2012 and the Teaching Excellence Award from the UT College of Pharmacy in 2013.
Disclosure: Dr. Stephen Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:
Speakers Bureau: Actavis, Otsuka, Sunovion
Consultant: Janssen, Jazz, Otuska, Teva
Other: Member of Pharmacists Foundation, Business Development Council for San Antonio
Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.
Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.
Discuss the use of testing with various demographics and its impact on treatment/i.e. cost, access, recommendations, etc.
Determine how to use pharmacogenomic testing in practice using an evidence-based approach. including evidence behind their use, the limitations of tests, and where to obtain resources for implementation.
About the Speaker
Vicki Ellingrod, Pharm.D., FCCP, FACNP
Dean and J. G. Searle Professor of Pharmacy, College of Pharmacy
Professor of Psychiatry, Medical School
Adjunct Professor of Psychology, College of Literature, Science, and Arts
The University of Michigan
Vicki L. Ellingrod, Pharm.D., FCCP, FACNP, is the Dean of the College of Pharmacy at the University of Michigan and the John Gideon Searle Professor of Translational Pharmacy. She is also a professor of Psychiatry and Psychology within the Medical School and College of Liberal Arts and Sciences. Within the University of Michigan, she serves as associate director of the Michigan Institute for Clinical and Health Research (MICHR), and principal investigator for the KL2 program, which provides training and mentoring in translational research for health professionals and junior faculty. Both of these initiatives are competitively supported by the National Center for the Advancement of Translational Science (NCATS). She obtained her bachelor’s and PharmD from the University of Minnesota and then completed a postdoctoral fellowship in psychopharmacology/pharmacogenetics at the University of Iowa, followed by joining the faculty there as an assistant professor. Her research has focused on the identification of genetic markers related to drug response in mental illness and has been funded by NIMH (National Institute of Mental Health) the FDA, and industry. Prior to joining the faculty at the University of Michigan, Dr. Ellingrod was a practicing clinical pharmacist working on the medical psychiatry unit at the University of Iowa Hospitals and Clinics. Dr. Ellingrod is a founding member of the College of Psychiatric and Neurologic Pharmacists and a fellow of the American College of Neuropsychopharmacology (ACNP), as well as the American College of Clinical Pharmacy (ACCP). She also serves as a scientific editor for Pharmacotherapy and the Journal of Clinical and Translational Science and is an editor on the textbook DiPiro’s Pharmacotherapy a Pathophysiologic Approach.
Disclosure: Vicki Ellingrod does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Discuss research on the use of cannabis as a treatment for mental health
Discuss research where cannabis may worsen or lead to mental health issues, particularly with younger patients
Discuss access and understanding of treatment use among underrepresented populations
About the Speaker
Thida Thant, M.D.
Assistant Professor of Psychiatry
University of Colorado Medicine
Dr. Thida Thant is a faculty psychiatrist at the University of Colorado Department of Psychiatry and is the Director of the Consultation-Liaison Psychiatry Service and the Psychiatric Consultation for the Medically Complex clinic, and the Assistant Chief of Service for the Psychiatry Community Practices. She graduated with a BA in Plan II Honors from the University of Texas in Austin, attended the University of Texas Medical School in Houston and completed her psychiatry residency and CL fellowship at the University of Colorado. Her professional interests include cannabis in medical education and comprehensive mental health care for medically and neurologically complex patients, with a more recent focus on long-haul COVID. She has written about cannabis and psychiatric care in books such as Marijuana and Mental Health and Cannabis in Medicine and has published an AAMC MedEdPortal curriculum entitled "What You Need to Know About Cannabis: An Evidence-Based Crash Course for Mental Health Trainees" as well as a Springer publishing book titled "Cannabis in Psychiatric Practice: A Practical Guide". In her spare time, she enjoys cycling, skiing, paddleboarding and hanging out with her pups Wall-E and Reba.
Disclosure: Dr. Thida Thant does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
List the Basic Principles of Malpractice/Liability Law
Identify Common Areas of Risk for Psychiatrists and Mental Health Providers
Review select Cases in Forensic Psychiatry exemplifying Liability Risk
Discuss Examples of Improving Documentation to Reduce Liability Risk.
About the Speaker
Martin Guerrero, M.D., J.D.
Medical Director and Founder
TMS Institute of El Paso
Board Certified, Adult, Forensics, Geriatrics
Dr. Guerrero currently serves as the Medical Director of Forensic Services at the El Paso Psychiatric Center; Senior Examiner at the American Board of Psychiatry & Neurology; Vice Chair of the Substance Abuse Task Force at the American Bar Association; and the Medical Reviewer for Psychiatry at El Paso First Health Plans, Inc.
Disclosure: Dr. Martin Guerrero has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:
Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.
Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.
Describe provider attitudes and perceptions towards tapering benzodiazepines.
Discuss the clinical utility of benzodiazepines.
Describe risks associated with long-term benzodiazepine use. Discuss strategies to assist with benzodiazepine deprescribing.
About the Speaker
Lisa M. Mican, Pharm.D., BCPP
Director of Pharmacy, Clinical Coordinator
Austin State Hospital
Lisa M. Mican, Pharm.D., BCPP is the Director of Pharmacy for the Austin State Hospital. She obtained her Pharm.D. from the University of Texas in 2000 and completed her psychiatric residency training at the Audie L. Murphy VA Hospital in San Antonio. Dr. Mican is a Board-Certified Psychiatric Pharmacist since 2003 and has mentored over 130 pharmacy residents and student interns on rotation at the Austin State Hospital from UT Austin and Texas A&M Kingsville Colleges of Pharmacy. She received the Texas Health and Human Services Patient Care Hospital Hero Award in 2018. Recent presentations include “Clinical Pharmacy Services in an Inpatient Psychiatric Hospital” at the European Society of Medicine Congress Vienna, Austria 2021 and “Benzodiazepine Statewide Workgroup” co-presentation with Dr. Beadles for the Texas Health and Human Services 2022. In her free time, she enjoys writing exam questions for the Board of Psychiatric Specialties certification exam and serving as a manuscript peer reviewer for pharmacy and psychiatry journals. Just kidding- she enjoys hiking and off-roading in the rural wilderness of the US.
Disclosure: Dr. Lisa Mican does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
M. Elizabeth Deel Flores, MSN, M.S., R.N., APRN, PMHNP-BC
Assistant Clinical Director
Austin State Hospital | HHSC Health and Specialty Care System
Texas Health and Human Services Commission
M. Elizabeth Deel Flores is a Board Certified Psychiatric and Mental Health Nurse Practitioner and the Assistant Clinical Director of Austin State Hospital (ASH). She has been a valued member of the ASH family since October 2015. Clinically, Elizabeth specializes in providing inpatient mental health care to adults with intellectual and developmental disabilities. Administratively, she serves as a member of the executive leadership team and oversees many administrative functions of the Medical Staff department. She supervises the departments of Social Work, Psychology, Education and Rehabilitation, Nutrition, and Rehabilitation Therapy.??In her current role, she serves on several committees which includes Chairing the Pharmacy and Therapeutics Committee at Austin State Hospital and serving as a medical staff representative on the statewide Pharmacy and Therapeutics Subcommittee for Texas State Hospitals. Elizabeth graduated with a BS with honors in biology from the University of Kentucky and earned an MS in cellular and molecular neuroscience from Vanderbilt University and an MSN in psychiatric and mental health nursing from Vanderbilt University School of Nursing. As a former scientist, she gets very jazzed about data and works with her teams to incorporate evidence-based interventions both clinically and administratively. Elizabeth enjoys watching stand-up comedy, reading interesting fiction, visiting the mountains, and going on family adventures with her husband and three-year-old daughter. Note: As doing literally anything with a 3-year-old child could be euphemized as an “adventure,” the term is being used very lightly here. ?
Disclosure: Elizabeth Deel Flores does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
A Clinician's Guide to the Management of Behavioral and Psychological Symptoms of Dementia
Learning Objectives
Describe the epidemiology of Behavioral and Psychological Symptoms of Dementia (BPSD)
Elucidate the neurobiology and assessment of individuals with BPSD
Discuss the management of individuals with BPSD
Describe the ethical controversies in the treatment of individuals with BPSD
About the Speaker
Rajesh R. Tampi, M.D., M.S., DFAPA, DFAAGP
Professor and Chairman
Department of Psychiatry
Creighton University
Dr. Tampi is the Professor (Tenured) and Chairman of the Department of Psychiatry, Inaugural Bhatia Family Endowed Chair in Psychiatry at Creighton University School of Medicine and Catholic Health Initiatives (CHI) Health Behavioral Health Services in Omaha, Nebraska. Dr. Tampi is also a Professor (Adjunct) of Psychiatry at Yale School of Medicine in New Haven, Connecticut. Dr. Tampi is the inaugural Historian of the American Association for Geriatric Psychiatry (AAGP). He is also a Past President of the AAGP. Dr. Tampi is a recipient of the Geriatric Academic Career Award (GACA) instituted by the Department of Health and Human Services (DHHS). He was a recipient of the AAGP’s ‘Clinician of the Year Award’ in 2013. Dr. Tampi also received the AAGP’s ‘Recognition and Appreciation’ Certificate in 2018. In 2019, he received the AAGP’s ‘Educator of the Year Award’. Dr. Tampi received the ‘2019 Outstanding Academician of the Year Award’ given by the Indo-American Psychiatric Association (IAPA). He is the recipient of the 2021 ‘Jack Weinberg Award’ for Geriatric Psychiatry given by the APA. Dr. Tampi has been honored with the 2022 ‘George Tarjan Award’ by the APA. Dr. Tampi has over 200 publications on various topics in Psychiatry and Geriatric Psychiatry. In addition, he is the Editor of 10 books in Psychiatry and Geriatric Psychiatry. Dr. Tampi serves as an Editor-in-Chief of the World Journal of Psychiatry. He is also a Triage Editor for International Psychogeriatrics, an Associate Editor for Drugs in Context (Psychiatry), an Associate Editor for the Aging Psychiatry Section of Frontiers in Psychiatry and the Section Editor of Geriatric Psychiatry for Psychiatric Times.
Disclosure: Dr. Rajesh Tampi does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Identify evidence-based treatment guidelines used in gender-affirming care
Recognize the hormone therapies of gender-affirming care
Examine the occurrence of mental health symptoms and disorders in gender-diverse individuals
Assess medication management options for mental health disorders in gender-affirming care
About the Speaker
Carol A. Ott (she/her), Pharm.D., BCPP
(pronouns: she/her)
Clinical Professor of Pharmacy Practice
Clinical Pharmacy Specialist
Psychiatry and Gender Health
Eskenazi Health
Purdue University College of Pharmacy
Carol Ott, Pharm.D., BCPP is a clinical professor of pharmacy practice at the Purdue University College of Pharmacy and adjunct faculty in the Department of Psychiatry at the Indiana University School of Medicine. She teaches psychiatric and neurologic pharmacotherapy at Purdue and didactics in psychopharmacology in the IU Psychiatry Residency Program. Carol is a clinical pharmacy specialist in outpatient psychiatry and gender health at Eskenazi Health in Indianapolis, working under collaborative practice agreements in the Gender Health program to provide medication management and monitoring services. At Purdue, Dr. Ott is the faculty lead for mental health and gender health in the Center for Health Equity and Innovation (CHEqI). She serves as the faculty advisor for AAPP Purdue student chapter and QueerRx in the College of Pharmacy. Dr. Ott is a member of the Indiana Medicaid Drug Utilization Review Board, Psychotropic Medication Advisory Committee, and Mental Health Quality Advisory Committee and serves as an expert panelist for the Project ECHO for Opioid Use Disorders through the IU School of Medicine and the LGBTQ+ ECHO through IU Fairbanks School of Public Health. She is a past secretary of the board of directors for the American Association of Psychiatric Pharmacists (AAPP) and a past member of the AAPP Foundation Board. Dr. Ott is an editor for the AAPP Psychiatric Pharmacotherapy Review Course for Board Certification in Psychiatric Pharmacy (BCPP). In the Lafayette, Indiana community, Dr. Ott is the president of the board of directors for NAMI West Central Indiana and serves on the executive board of the Gateway to Hope Syringe Service Program for the Tippecanoe County Health Department.
Disclosure: Dr. Carol Ott does relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Discuss recent updates in the use of antipsychotic medication in relation to pregnancy and lactation
Discuss evidence-based guidelines for continued use of antipsychotic medication during pregnancy and lactation
About the Speaker
Jeffrey Newport, M.D.
Director of Women's Reproductive Mental Health
UT Health Austin
Dr. Jeffrey Newport is a Professor of Psychiatry and Women’s Health at the University of Texas at Austin Dell Medical School. Dr. Newport completed a graduate theological degree before receiving his medical degree from the University of South Carolina. He subsequently completed a psychiatric residency and a master’s degree in clinical research at Emory University. His awards include the NARSAD Independent and Young Investigator Awards, Young Faculty Award from the American Psychiatric Institute for Research and Education, the Society of Biological Psychiatry’s Lilly Fellowship, the American College of Psychiatrists’ Laughlin Fellowship, and the Distinguished Physician Alumnus Award from the University of South Carolina. He has published in leading journals across numerous specialties including JAMA, American Journal of Psychiatry, American Journal of Obstetrics & Gynecology, Neurology, and Pediatrics. Dr. Newport’s research focuses on women’s mental health with an emphasis on the psychobiology of perinatal psychiatric disorders, psychotropic pharmacokinetics during pregnancy and lactation, and the persistent biobehavioral impact of childhood trauma and other early life adverse experiences.
Disclosure: Dr. Jeffrey Newport does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Discuss the epidemiology of depression in youth, including issues with diverse populations.
Summarize the evidence for the pharmacotherapy of depression in youth, including new approaches to treatment.
Interpret the boxed warning for antidepressants in youth and place it into perspective for the clinician.
About the Speaker
M. Lynn Crismon, Pharm.D., FCCP, DABCP, BCPP
Professor of Pharmacy & Psychiatry
The University of Texas at Austin
M. Lynn Crismon is a Professor of Pharmacy and Psychiatry at The University of Texas at Austin. He is the former Behrens Centennial Professor of Pharmacy and past Dean and James T. Doluisio Regents Chair of the College of Pharmacy. He is board-certified in psychiatric pharmacy and a Diplomate of the American Board of Clinical Pharmacology. His research has focused on improving the pharmacotherapy of severe mental disorders and mental health outcomes research. He has over 270 publications and 210 abstracts. Since 2004, he has co-led the development and the updating of the Psychotropic medication utilization parameters for children and youth in Texas Public Behavioral Health. He is a founding steering committee member, faculty member, and coach in the REACH Institute’s Patient-Centered Mental Health in Pediatric Primary Care Mini-fellowship. He served as a member of the National Academy of Medicine Committee that developed Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being which received the 2021 James A. Hamilton Book Award from the American College of Healthcare Executives.
Disclosure: Dr. M. Lynn Crismon does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Review recommended use and laws surrounding the Texas Prescription Monitoring Program
Introduce the “RAISED” acronym for elevating communication
Discuss using non-stigmatized and inclusive language
Practice making educated language decisions that address common situations around controlled substances
About the Speaker
Kirk Evoy, Pharm.D., BCACP, BC-ADM, CTTS
Clinical Associate Professor
The University of Texas at Austin College of Pharmacy
Kirk E. Evoy is a Clinical Associate Professor in the Pharmacotherapy Division of the College of Pharmacy at The University of Texas at Austin, as well as an Adjoint Associate Professor in the School of Medicine at the University of Texas Health San Antonio. In addition to his teaching and research responsibilities within the college, Dr. Evoy also cares for patients as an ambulatory pharmacist at University Health in San Antonio.
Dr. Evoy completed his Pre-pharmacy and Doctor of Pharmacy coursework at Purdue University. Upon completion of pharmacy school, he went on to complete a PGY1 Pharmacy Practice Residency at the University of Wisconsin Hospital and Clinics in Madison, Wisconsin followed by a PGY2 Ambulatory Care Residency at Saint Joseph Regional Medical Center in Mishawaka, Indiana. In addition to his residency training, Dr. Evoy completed two teaching certificate programs and a Certificate of Added Training in Global Health and has earned Board Certification as an Ambulatory Care Pharmacist (BCACP), Advanced Diabetes Manager (BC-ADM), and Tobacco Treatment Specialist (CTTS).
Dr. Evoy’s primary areas of research include substance use disorders and smoking cessation. His clinical focus is primary care, particularly diabetes management, and smoking cessation, with additional interests in transitions of care and global health.
Disclosure: Dr. Kirk Evoy does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Breaking Issues in Opioid Use Disorder Treatment and Harm Reduction
Learning Objectives
Summarize recent legal and regulatory changes impacting OUD care
Identify barriers and facilitators to pharmacist collaboration in OUD care
Plan to integrate evidence-based OUD care in pharmacy practice
About the Speaker
Lucas G. Hill, Pharm.D., BCACP
Clinical Associate Professor
The University of Texas at Austin College of Pharmacy
Director, Pharmacy Addictions Research & Medicine Program
Lucas G. Hill graduated from the University of Missouri-Kansas City School of Pharmacy and completed a combined family medicine residency and faculty development fellowship at the University of Pittsburgh Medical Center. He is now a clinical associate professor at The University of Texas at Austin College of Pharmacy where he serves as director of the Pharmacy Addictions Research and Medicine (PhARM) Program and holds the Bergen Brunswig Corporation Centennial Fellowship. Dr. Hill is the principal investigator for a Texas Targeted Opioid Response project which seeks to address the opioid crisis in Texas by educating health professionals and conducting pragmatic research. He is an editorial board member for the Journal of the American College of Clinical Pharmacy and a past chair of the American Association of Colleges of Pharmacy Substance Use Disorder Special Interest Group. Dr. Hill has been recognized with several prestigious national awards, including the American College of Clinical Pharmacy New Educator Award and the American Pharmacists Association Generation Rx Award of Excellence.
Disclosure: Dr. Lucas Hill does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Using the PMP and Communicating with Patients Concerning Controlled Substance Prescriptions
Learning Objectives
Review the laws and regulations surrounding The Texas Prescription Monitoring Program (PMP).
Summarize the current atmosphere in the United States surrounding substance use disorder and Opioids for Pain.
Explore the 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Chronic Pain.
Demonstrate best practices for operating the PMP, documenting PMP interventions, and discussing these interventions with patients.
About the Speaker
Dr. K. Ashley Garling-Nañez, Pharm.D.
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
Dr. Ashley Garling graduated Rho Chi with honors from the MCV/Virginia Commonwealth University School of Pharmacy. Her career path went from community pharmacy management, inpatient pharmacy with an oncology focus, to corporate clinical coordinator, and media spokeswoman. She is now a clinical assistant professor at The University of Texas at Austin College of Pharmacy where she serves as a communication, media, and patient engagement specialist. Dr. Garling is the principal investigator (PI) and Co-PI for research projects in community pharmacy settings spanning telehealth, HIV PrEP, mental health, patient counseling, and medication adherence. She currently serves as president of the Capital Area Pharmacist Association, Affairs Public Policy Council Member, and Public Policy Council Member of the Texas Pharmacist Association. Her career pillars are focused on public activation, empowerment of underheard voices, and health education. In 2020-21, Dr. Garling was awarded the Dr. Carolyn Brown DEAI Champion Award and the 2021 Teaching Excellency Award in recognition of her outstanding contributions to diversity, inclusion, and pharmacy education.
Disclosure: Ashley Garling does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Describe multimodal approaches to pain in the hospitalized patient
Evaluate/optimize a pain management regimen for patients with comorbid conditions
Discuss best practices for opioid stewardship in the hospital setting
About the Speaker
Lyndsi Meyenburg, Pharm.D., BCPS
Clinical Pharmacy Specialist, Internal Medicine
Residency Program Director, PGY2 Internal Medicine Pharmacy
Residency, Pharmacy Department, Ascension Seton
Lyndsi Meyenburg is an Internal Medicine Clinical Pharmacy Specialist at Ascension Seton in Austin, Texas. She earned her Doctor of Pharmacy degree in 2011 from St. Louis College of Pharmacy in St. Louis, Missouri. She completed her PGY1 Residency at Mercy Hospital St. Louis and her PGY2 Internal Medicine Residency at VA St. Louis Healthcare System - John Cochran Division. Dr. Meyenburg has practice experience treating acute and chronic pain in hospitalized patients and is one of the leaders supporting initiatives for opioid use disorder, opioid stewardship, and pain management for Ascension.
Disclosure: Dr. Lyndsi Meyenburg does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Managing Buprenorphine in Hospitalized Patients with Opioid Use Disorder
Learning Objectives
Discuss buprenorphine management in both the initiation and maintenance phases
Discuss challenging clinical scenarios including patients with acute pain and shared decision-making regarding buprenorphine therapy in the peri-operative period
About the Speaker
Kristin Janzen, Pharm.D., BCPS
Clinical Assistant Professor, Pharmacy Practice
The University of Texas at Austin College of Pharmacy
Internal Medicine Clinical Specialist, Dell Seton Medical Center
Kristin Janzen is a Clinical Assistant Professor at the University of Texas at Austin College of Pharmacy. After graduating from UT College of Pharmacy, she completed a combined PGY1 & 2 Pharmacotherapy residency at Butler University and Indiana University Health in Indianapolis, IN. She currently practices at Dell Seton Medical Center at the University of Texas in Internal Medicine, where she precepts fourth-year PharmD students and pharmacy residents on academic internal medicine rotations. She teaches throughout the didactic curriculum at the UT College of Pharmacy, focusing on pharmacotherapeutics, clinical pharmacokinetics, and application-based pharmacy practice labs. She has been recognized for both didactic and experiential teaching and has been awarded the UT Austin College of Pharmacy Educator of the Year, the Austin-Temple-Waco Region Preceptor of the Year, and Wm. Arlyn Koesel Preceptor of the Year Awards. She has also been recognized by the UT Center of Health Interprofessional Practice and Education (IPE) as a Health IPE Fellow. Her research and teaching interests focus on student preparedness for residency, interprofessional education, and core medicine disease states, such as pulmonology, cardiology, and diabetes.
Disclosure: Dr. Kristin Janzen does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
• Describe the risks of comorbid psychiatric and medical comorbidities in people with Attention-deficit/hyperactivity disorder (ADHD)
• Explain the risks and prevention of medication diversion and misuse in people with ADHD
• Design an individualized management plan for people with ADHD
About the Speaker
Stephen R. Saklad, Pharm.D., BCPP
Director, Psychiatric Pharmacy Program
Pharmacotherapy Education and Research Center
UT Health Science Center San Antonio
Dr. Saklad is a Clinical Professor at The University of Texas College of Pharmacy and a Pharmacist at San Antonio State Hospital since 1979. He has focused his career on clinical care, teaching, and research to improve the quality of life and function in the serious and persistently mentally ill. He helped to create a clinical research unit at San Antonio State Hospital and developed the first websites for The University of Texas College of Pharmacy and the College of Psychiatric and Neurologic Pharmacists (CPNP). He is the Director of the University of Texas Psychiatric Pharmacy Program in San Antonio, having trained over 70 advanced practice pharmacists in psychiatric pharmacy. Dr. Saklad is a Founding Member of CPNP, served on the CPNP Board of Directors and was the founding senior editor of their peer-reviewed journal, the Mental Health Clinician. He has published articles and presented to many groups around the country on a variety of pharmacy and mental health-related topics. He is a principal or co-investigator for several studies of the efficacy and adverse effects of Phase II, III, and IV psychotropic agents in schizophrenia, mood disorders, and other serious mental illnesses, as well as their pharmacokinetics and interactions. He has received several honors, most recently the Judith J. Saklad Memorial Award from CPNP in 2012 and the Teaching Excellence Award from the UT College of Pharmacy in 2013.
Disclosure: Dr. Stephen Saklad has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:
Speakers Bureau: Actavis, Otsuka, Sunovion Consultant: Janssen, Jazz, Otuska, Teva Other: Member of Pharmacists Foundation, Business Development Council for San Antonio
Treatment of Agitation in Neurocognitive Disorders
Learning Objectives
Evaluate evidence and risk vs. benefit of medication treatment as well as any nonmedication modalities.
Discuss the importance of the “Black Box” warning for antipsychotics and the process of informed consent.
Review new and emerging therapies as well as risks associated with current pharmacotherapies.
Describe the ethical quandaries when prescribing antipsychotics for agitation
About the Speaker
Jason E. Schillerstrom, M.D.
The Biggs Institute for Alzheimer’s and Neurodegenerative Diseases
UT Health San Antonio
Dr. Jason Schillerstrom is a Professor of Geriatric Psychiatry at UT Health San Antonio. He provides clinical care to elders with mood, anxiety, and cognitive disorders. He serves as a consultant to Adult Protective Services and local attorneys who request decisional capacity assessments for elders suffering from neglect or exploitation. Dr. Schillerstrom is the Residency Program Director for Psychiatry where he teaches and guides 78 civilian and active duty psychiatrists in training.
Disclosure: Dr. Schillerstrom has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
Human Trafficking Prevention: Pharmacy Perspective
This course is approved for only CPE, CME, CEU continuing education credit. The course is approved by the Texas HHSC for meeting the Human Trafficking Prevention credit for all healthcare providers.
Describe different types of human trafficking and their local, statewide and international prevalence
Identify potential signs of human trafficking in victims who present for care in a medical setting
Discuss the immediate healthcare needs of identified victims and develop the ability for trauma-informed response
Describe available resources for victim service and aftercare
About the Speakers
Kerri Taylor, M.S., ccc-slp
Executive Director at Unbound Houston
Kerri Taylor is the Executive Director of Unbound Now Houston, the local chapter of Unbound Now, an international anti-human trafficking organization that focuses on domestic minor sex trafficking with specific emphasis on prevention efforts with at-risk youth. Unbound works to activate the community to fight human trafficking and is dedicated to public awareness, prevention education, professional training, and survivor advocacy. Kerri serves on the board of the Brazoria County United Front Coalition to Fight Human Trafficking. In addition to being a member of the Child Sex Trafficking Advisory Council of Harris County, she works closely with the No Trafficking Zone, established in 2020 and with NRG stadium. Unbound Now Houston’s advocates are onsite at every Texans home football game, providing services for identified victims. In addition, she serves alongside other advocates in Galveston and Brazoria County as a coordinated response protocol for identified victims of human trafficking is developed.
Kerri earned a Bachelor's degree in Education from Baylor University with a specialization in Speech Pathology and Audiology and subsequently, a Master's Degree in Speech Pathology and Audiology from the John A. Burn School of Medicine at the University of Hawaii. She is retired from private practice, having served in the acute, skilled nursing, rehabilitation and home health settings specializing in neurogenic speech and swallow disorders.
The University of Texas at Austin College of Pharmacy
Dr. Claire Latiolais graduated from Purdue University with a Doctor of Pharmacy degree in 2015. She went on to complete an ASHP-accredited Health-System Pharmacy Administration residency in The Houston Program at Texas Children’s Hospital in Houston, TX. Along with this program, she completed her Master’s in Pharmacy Leadership and Administration from the University of Houston College of Pharmacy. She joined the faculty at The University of Texas at Austin College of Pharmacy (UTCOP) in 2018 and served as a Clinical Assistant Professor in the Department of Pharmacy Practice. Her role included serving as the Course Coordinator for the Institutional Introductory Pharmacy Practice Experience (I-IPPE). Additionally, her responsibilities included teaching Drug Information, Applied Pharmacy Management, Clinical Skills and Hospital Pharmacy, as well as serving as the Student Society of Health-System Pharmacists (SSHP) faculty advisor and Chair of the Admissions Committee. In the fall of 2022, Dr. Latiolais transitioned into a new role at The University of Texas MD Anderson Cancer Center as a Clinical Pharmacy Specialist of Drug Information and Formulary Management. In addition, Dr. Latiolais continued an appointment with UTCOP as the Experiential Regional Director for Houston. Dr. Latiolais is a member of several professional organizations, including the American Society of Health-System Pharmacists (ASHP) where she served on the 2019-2020 New Practitioners Forum Executive Committee, the Texas Society of Health-System Pharmacists (TSHP) where she serves on the Education Affairs Council, the Central Texas Society of Health-System Pharmacists (CTSHP) where she served as a Board Member, Phi Lambda Sigma, Phi Delta Chi, and Rho Chi. Her interests include drug information, formulary management, experiential education, professional development of students, servant leadership, hospital operations, and pharmacy management.
The University of Texas at Austin College of Pharmacy
Dr. Kubes was born and raised in Houston, Texas. She graduated from Texas A&M University in 2006 with a B.S. in Biomedical Sciences, then attended the University of Houston College of Pharmacy and graduated in 2011. Dr. Kubes continued her post-graduate education as a PGY1 resident at Memorial Hermann Hospital in the Houston Medical Center and then a PGY2 pediatrics residency at Children’s Memorial Hermann Hospital. Following residency, she accepted a position as a Pediatric Critical Care Clinical Specialist at Cincinnati Children’s Hospital. In 2014, she relocated to San Antonio and took on the role of the Pediatric Infectious Diseases and Antimicrobial Stewardship Pharmacist at The Children’s Hospital of San Antonio. Dr. Kubes joined the UT group in 2018 as a Clinical Assistant Professor in the Pharmacotherapy Division of the College of Pharmacy at The University of Texas at Austin, as well as an Adjoint Assistant Professor in the School of Medicine and The Department of Pediatrics at the University of Texas Health Science Center at San Antonio. In addition to her teaching and research responsibilities within the college, Dr. Kubes is also responsible for clinical pharmacy services and caring for pediatric patients within the University Health System in San Antonio. Dr. Kubes also sits on the CTSHP board as a senior board member, has been appointed by the Texas Attorney General’s office and the Texas Health and Human Services Commission as a Texas Medicaid Drug Utilization Review Board Member, serves as the Chair for the UT-affiliated Residency Programs and vice chair for the general pediatrics special interest group for the Pediatric Pharmacy Association national organization. Her primary areas of research include quality improvement in pediatrics, cystic fibrosis and infectious diseases. Her clinical interests include pediatrics, infectious diseases and maternal health. In her spare time, she is a mom to 3 children, an avid gardener, baker, reader and chicken/turkey/pheasant/duck/quail/bunny/piggy tender.
Ashley Garling, Pharm.D.
Clinical Assistant Professor of Pharmacy Practice
UT College of Pharmacy
President, Capital Area Pharmacist Association
Dr. Ashley Garling graduated Rho Chi with honors from the MCV/Virginia Commonwealth University School of Pharmacy. Her career path went from community pharmacy management, inpatient pharmacy with an oncology focus, to corporate clinical coordinator, and media spokeswoman. She is now a clinical assistant professor at The University of Texas at Austin College of Pharmacy where she serves as a communication, media, and patient engagement specialist. Dr. Garling is the principal investigator (PI) and Co-PI for research projects in community pharmacy settings spanning from telehealth, HIV PrEP, mental health, patient counseling, and medication adherence. She currently serves as president of the Capital Area Pharmacist Association, Affairs Public Policy Council Member, and Public Policy Council Member of the Texas Pharmacist Association. Her career pillars are focused on public activation, empowerment of underheard voices, and health education. In 2020-21, Dr. Garling was awarded the Dr. Carolyn Brown DEAI Champion Award and the 2021 Teaching Excellency Award in recognition of her outstanding contributions to diversity, inclusion, and pharmacy education.
AbbVie is driving the pursuit of improved mental health. Over the last 3 years, the company’s scientists and clinicians have worked to tackle the complexity of mental illness and today offer a portfolio of medicines and a pipeline of innovation that spans depression, anxiety, bipolar disorder, and schizophrenia. To learn more about AbbVie’s work to support individuals throughout their mental health journey, please visit www.abbvie.com or follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
We're glad you stopped by and hope that you aspire to become part of the CMC family. UTMB CMC employs a diverse workforce committed to service, education, community, and innovation.
Applicants interested in applying for jobs within Correctional Managed Care should click on http://www.utmb.edu/careers/. Please contact Kevin Martin, Sr. Recruiter/Human Resources - Correctional Managed Care (CMC) at 409-747-2694 or kelmarti@utmb.edu.
The future looks promising for UTMB Correctional Managed Care Employees. UTMB Correctional Managed Care is a unique place to operate as a health professional, offering you the opportunity to work in a stimulating, independent and multifaceted workplace. Our healthcare system redevelopment offers valuable and timely experience in innovative care while providing opportunities in clinic management.
As a UTMB Correctional Managed Care employee, you are a member of a premier healthcare network that currently includes over 3,100 employees serving 110,000 patients. Not only will you be exposed to a managed care environment, you will be critical to its success. Your efforts will be valued, respected, and recognized.
Contact:
Kevin Martin
Sr. Recruiter/Human Resources – Correctional Managed Care (CMC)
1560 W. Bay Area Blvd. Ste. 100 Friendswood, TX 77546
Thank you for visiting the Teva Medical Affairs page. The primary role of the Teva. Medical Affairs organization is to educate and communicate scientific information and generate new data. Our field medical teams, consisting of Medical Science Liaisons (MSLs) and Value, Evidence, and Outcomes Liaisons (VEOs), focus particularly on specific therapeutic areas – psychiatry and movement disorders. MSLs serve as a non-promotional, objective, scientific resource both internally and externally for the company. They engage with a variety of healthcare providers (HCP) through different activities, including presentations, one-on- ones, and conferences allowing for a two-way flow of information between the HCP and the company. VEOs focus on communicating a product’s value proposition and health outcomes data to payers. To submit a request to meet with your MSL or VEO, please visit Medical Request Form
Sana Qureshi, Pharm.D., BCPS
Medical Science Liaison
Sana.Qureshi@tevapharm.com
TITLE
CONTENT OVERVIEW
LINK
CNSBytes.UsWebsite
Information and articles related to schizophrenia, tardive dyskinesia (TD), Huntington’s disease, and migraine
Loading, please wait...
Continuing Pharmacy Education: The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This two-day activity is approved for 22.0 CEUs (14 contact hours live with 8 on-demand) of continuing education credit. In order to receive 22.00 contact hours of CE credit, the participant must attend/participate in all sessions of the program, and complete the online evaluations for each session.
